GENX logo

Genix Pharmaceuticals Corporation Stock Price

TSXV:GENX Community·CA$1.2m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

GENX Share Price Performance

CA$0.02
-0.03 (-60.00%)
CA$0.02
-0.03 (-60.00%)
Price CA$0.02

GENX Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk with weak fundamentals.

5 Risks
0 Rewards

Genix Pharmaceuticals Corporation Key Details

CA$0

Revenue

CA$0

Cost of Revenue

CA$0

Gross Profit

CA$335.1k

Other Expenses

-CA$335.1k

Earnings

Last Reported Earnings
Oct 31, 2025
Next Reporting Earnings
n/a
-0.0055
0%
0%
-73.5%
View Full Analysis

About GENX

Founded
1993
Employees
n/a
CEO
Sina Pirooz
WebsiteView website
genixpharm.com

Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with a focus on nutraceuticals and pharmaceuticals in Canada. The company offers generic ophthalmic prescription products, ophthalmic nutraceutical formulations, and prescription generic drugs; ophthalmic OTC products; and eye ointments and drops. It also provides Flu-X, an anti-viral, anti-flu, and common colds coronavirus oral and spray herbal product; Rechlor, a dietary supplement to support kidney health; Sucanon, an herbal health supplement to manage blood sugar levels and enhance insulin sensitivity in non-insulin dependent adults; and Synthroid, a levothyroxine sodium drug for the treatment of hypothyroidism. The company was formerly known as Alta Natural Herbs & Supplements Ltd. and changed its name to Genix Pharmaceuticals Corporation in June 2019. Genix Pharmaceuticals Corporation was incorporated in 1993 and is based in Vancouver, Canada.

Recent GENX News & Updates

Recent updates

No updates